Jitesh Joshi MD

Oncology•Houston, TX

Hematologic Oncology

Telehealth available

Request appointment

2060 Space Park Drive, Suite 112Houston Methodist St John, Hematology OncologyHouston, TX 77058
Book by Phone+1(832) 688-4170

Overview of Dr. Joshi

Jitesh Joshi, MD, is a board-certified hematologist and medical oncologist with 12 years of independent clinical experience across academic-affiliated community oncology, rural medicine, clinical research, and multidisciplinary cancer care. He currently practices at Houston Methodist Clear Lake, where he serves as Medical Director of the Infusion Suite and cares for patients with solid tumors, hematologic malignancies, and benign hematologic disorders.

Dr. Joshi has played a central role in the development of the Clear Lake cancer program. He chairs the Commission on Cancer Accreditation Committee, moderates the general oncology and breast multidisciplinary tumor boards, and contributes to systemwide clinical-performance, chemotherapy-stewardship, and quality-improvement initiatives. His work has focused on strengthening coordinated cancer care, integrating supportive services, and expanding access to high-quality oncology treatment and clinical research in the community setting.

As a sub-investigator with the Houston Methodist Neal Cancer Center, Dr. Joshi has participated in more than 25 Phase I–III oncology clinical trials. His research responsibilities have included patient identification, trial discussions, screening and enrollment, protocol implementation, adverse-event monitoring, and longitudinal follow-up. He has authored or coauthored peer-reviewed publications and published abstracts in lymphoma, thoracic oncology, hematologic malignancies, and other areas of cancer care.

Before joining Houston Methodist, Dr. Joshi practiced in rural Arkansas, where he helped establish an outpatient oncology clinic and infusion services at Drew Memorial Hospital, a critical access hospital. He also served as teaching faculty for the UAMS South Central Family Medicine Residency.

His professional interests include community-based clinical research, improving access to trials for underserved populations, multidisciplinary cancer care, physician education and QI projects

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2011 - 2014
University of ConnecticutResidency, Internal Medicine, 2008 - 2011
Maulana Azad Medical CollegeClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2017 - 2027
AR State Medical License 2014 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification CureMD SMART Cloud, CureMD.com, Inc., 2015-2017
CMS Meaningful Use Stage 2 Certification CureMD SMART Cloud, CureMD.com, Inc., 2015-2017

Publications & Presentations

PubMed

5 citations
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell ly...
Cesar Gentille, Humaira Sarfraz, Jitesh Joshi, Jasleen Randhawa, Shilpan Shah
Cancer Reports. 2022-07-01
19 citations
Primary Cutaneous Anaplastic Large-Cell Lymphoma (PC-ALCL): A review of the SEER database from 2005-2016
Humaira Sarfraz, Cesar Gentille, Joe Ensor, L Wang, Stephen T. C. Wong
Clinical and Experimental Dermatology. 2021-06-03
3 citations
Myelomatous Pleural Effusion as a Presenting Symptom: A Case Report.
Alejandro Rodelo, Jitesh Joshi
Cureus. 2019-07-16